MBX Biosciences Inc (MBX)

35.64 -2.97%

MBX Biosciences Inc (MBX) is currently trading at $35.64. This represents a loss of 2.97% from the previous session. With a market capitalization of $1.60B, MBX is a key component of the Consumer Entertainment sector. Investors looking to trade MBX should compare margin rates and options platforms to optimize their portfolio management.

Broker Promotion
Claim Your $300 Cash Bonus → T&Cs Apply. Trade MBX commission-free.
Trading Platform Comparison
Moomoo
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Good for small traders
IBKR
  • Min Deposit: $0
  • Commissions: $0–$0.005/share
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Professional-level tools
Ameritrade
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Strong research tools
Webull
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Easy mobile app
AI Market Sentiment

As of today, MBX Biosciences Inc (MBX) shows a bearish trend. Analysts are watching the 37.99 level closely.

Fundamentals
Mkt Cap1.60B
P/E Ratio0.0000
Volume477,763
Others Watching (By Market Cap)
PLUG
Plug Power Inc $1.91
+0.00% MARA
MARA Holdings I $8.57
+6.46% NVTS
Navitas Semicon $9.88
+19.61% IOVA
Iovance Biother $3.83
+1.32% RXRX
Recursion Pharm $3.77
+6.80%
60-Day Technical Chart
Advanced Charting

Need more indicators for MBX? Use the world's #1 platform.

Open MBX on TradingView →
Charting Platforms
TradingView

Advanced charts & indicators, web & mobile

StockCharts

Technical analysis charts with overlays & indicators

BarCharts

Market data, charts, and technical signals

Finviz

Visual stock charts & heatmaps

Yahoo Finance Charts

Basic interactive charts with indicators

Side-by-Side: Stocks Near $36
Metric MBX
-2.97% 		SMCI
+7.87% 		IONQ
+6.23% 		CMG
+2.82%
Price $35.64 $33.60 $33.59 $37.50
Mkt Cap $1.60B $20.22B $12.07B $48.80B
- View → View → View →
Latest Headlines
UBS Maintains Buy on MBX Biosciences, Inc. Common Stock (MBX) Feb 2026 Meyka • Feb 25, 2026 UBS reiterates Buy on MBX Biosciences stock, keeps $60 target Investing.com • Feb 24, 2026 (MBX) Long Term Investment Analysis (MBX:CA) Stock Traders Daily • Feb 23, 2026 MBX Biosciences execs join Feb–Mar health investor events Stock Titan • Feb 11, 2026 MBX Biosciences (MBX) Faces Platform Validation Challenge as Near-Term Hypoglycemia Data Catalyst in Q2 2026 May Lack Differentiation Yahoo Finance • Dec 15, 2025
● Gemini Agentic AI Analyst Insight for MBX
Market Education
View All Articles →
External Research